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 Background: Surgical management of pulmonary aspergillosis is 
challenging and controversial. This study is designed to assess the 
clinical profile, indications and surgical outcome of Pulmonary 
aspergilloma.  
Methods: A retrospective cross-sectional analysis of 72 patients 
who underwent pulmonary resection for pulmonary aspergilloma 
over the period from November, 2014, to November, 2019 was 
done. Data on demographic, clinical and surgical out come were 
retrieved. Analysis was done using SPSS version 23. Chi-square 
test was used to assess for significance of the association between 
variables and surgical outcome. 
Results: There were 46(63.9%) males and 26(36.1%) female 
patients with a mean age of 35.2+/-11.6 years (Range 16– 65 
years).  All patients were previously treated for tuberculosis. 
Cough, hemoptysis, and shortness of breath were the main 
symptoms identified. A ball of fungus together with the 
surrounding lung was removed. Accordingly, 32(44,4%) 
lobectomies, 12(16.7%) pneumonectomy, 7(9.7%) Bi-lobectomy, 
and 21(29.2%) cavernostomy were done. Intraoperative and 
Postoperative complications were seen in 8(11.1%) and 21(29.1%) 
patients respectively. Major morbidity encounters included 
massive intraoperative blood loss, prolonged air leak, empyema, 
air space, bronchopleural fistula, and wound infection. The 
hospital mortality was 3(4.2%) and the average hospital stay was 
14.8days. Postoperative complications were evaluated for the 
difference in socio-demographic characteristics and other 
variables and a statistically significant difference was detected 
only for the location of aspergilloma, site of the lung involved and 
type of surgery done. (P-value <0.05.) 
Conclusion: Pulmonary resection done for pulmonary 
aspergilloma showed favorable outcomes when done with good 
patient selection, meticulous surgical techniques, and good 
postoperative management. However, its long term outcome and 
role of antifungal treatment as adjunctive therapy for surgical 
resection need further investigation. 
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Pulmonary aspergilloma (PA) is a ball of fungus 
that is composed of Aspergillus hyphae, fibrin, 
mucus, and cellular debris within a pulmonary 
cavity (1). It usually arises within a preexisting 
pulmonary cavity that has become colonized 
with Aspergillus spp (2). The most common 
underlying pathology that predisposes to PA 
includes pulmonary tuberculosis, chronic 
obstructive pulmonary disease (COPD), prior 
pneumothorax with associated bulla and 
fibrocavitary sarcoidosis (3). Pulmonary cavities 
of ≥ 2cm which are left after the treatment of 
pulmonary tuberculosis have about 20% chance 
of developing PA (4).  
        Studies were done using modeling to 
estimate the global burden of PA as a sequel of 
pulmonary tuberculosis and showed in the range 
of <1 case/100,000 populations in western 
Europe and the USA to 42.9/100,000 population 
in Democratic Republic of Congo and Nigeria 
(5). Reflecting on the high frequency of 
pulmonary tuberculosis, Ethiopia has an 
estimated rate of 14.5 cases/100,000 population 
(6). 
The natural history of PA has been poorly 
studied. So far, there appears to be no consistent 
variable that helps to predict its outcome (7). 
The course of the disease is extremely variable, 
ranging from undergoing spontaneous lysis (7-
10%) to causing severe hemoptysis (8). In up to 
30% of patients, minor hemoptysis can go on to 
develop life-threatening hemoptysis (9). 
Besides, the severity of hemoptysis is also not 
related to the size, the number of aspergillomas 
nor to the underlying lung disease (10).  
        At present, there is a considerable 
controversy about the optimal treatment for PA, 
primarily because the natural history of the 
lesion is not well defined. Moreover, high 
morbidity and mortality have been reported from 
some surgical series (11-13). However, the 
current globally accepted mainstay of treatment 
is surgery and medical options have shown 
limited role. In light of the newer available anti-
fungal agents, treating with drugs, though 
disappointing, requires further investigation.  
         The purpose of this study was to evaluate 
the results for all patients who underwent 
pulmonary resection at Tikur Anbessa 
Specialized Hospital (TASH) and Menillik 2nd 
Hospital done for 72 consecutive patients with 
PA. 
  
PATIENTS AND METHODS 
 
A retrospective review of medical records and 
theatre operation register notes of patients 
operated for PA at Menillik 2nd and Tikur 
Anbessa Specialized Hospital (TASH) was 
done. Both hospitals are tertiary referral and 
teaching hospitals found in Addis Ababa, 
Ethiopia. 
         All patients diagnosed to have PA that 
underwent surgical treatment throughout 5 years 
(between Nov 30, 2014 – Nov30, 2019) were 
included. Socio-demographic variables, 
underlying previous diseases, symptoms, 
affected lobe of the lung, radiographic findings, 
indications, and types of surgery, intra-operative 
and postoperative complications, mortality, and 
the outcome of surgical interventions were 
analyzed. Most patients were referred for 
surgery from other regional hospitals after long-
term and repeated treatment of pulmonary 
tuberculosis. Preoperative assessment and 
diagnosis of PA were done based on clinical 
history, physical examination, blood urea 
nitrogen (BUN) and creatinine, Chest 
Radiography, and computed tomography of the 
chest. Pre-operatively for selected patients, 
pulmonary function tests and echocardiography 
assessment of left and right ventricular function 
and possible pulmonary hypertension (if present 
is a contraindication for surgery) were 
performed. Immune-diffusion tests or sputum 
culture for fungus is not routinely done.  
         Surgical resection was considered for 
patients with symptoms that justify operations 
like recurrent hemoptysis, recurrent pneumonia, 
shortness of breath (SOB) with localized ‘air-
crescent’ lesions on CT-Scan of the chest with 
local destruction of the lung and a good 
pulmonary reserve. Patients with poor 
pulmonary reserve or high risk to undergo 
thoracotomy, and those with concomitant active 
pulmonary tuberculosis were recommended to 
have conservative medical treatment. 
All patients were operated under general 
anesthesia. Based on the availability, either a 
single or double-lumen endobronchial intubation 
was done. Posterolateral thoracotomy was used 
to access the thoracic cavity. The choice of 
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resection (cavernostomy, lobectomy, bi-
lobectomy or pneumonectomy) is usually based 
on the general condition of the patient and the 
extent of the affected lung.  After surgery, most 
of the patients were extubated in the operating 
room and sent to the Intensive Care Unit (ICU). 
Some patients required ventilator support. 
Routine ICU or postoperative treatment protocol 
was followed during their hospital stay. Follow-
up was subsequently done in the Cardiothoracic 
surgical referral clinic with serial chest X-rays.  
        A structured questionnaire was used to 
collect relevant data from patients’ medical 
records and operation theater registry logbooks. 
Data was collected by final year surgery 
residents. Treatment success for this study was 
defined as a patient operated for PA and fully 
improved with no immediate complications seen 
during their hospital stay or subsequent follow-
up visit to the cardiothoracic surgical referral 
clinic. Data was then cross-checked for 
completeness, accuracy, and consistency before 
entry to a software program. Descriptive 
statistics as percentages, mean, and ranges were 
computed. Data were expressed as mean ± 
standard deviation (SD) for the variance of a 
normal distribution or as the median for those 
with non-normal distribution. Characteristics of 
the study subgroups were compared using 
Mann-Whitney U-test, for continuous variables, 
and Pearson Chi-Square test for categorical 
variables. The differences in postoperative 
complications were assessed by univariate 
analysis. Variables with significance on 
univariate analysis and previously known risk 
factors like age, sex, the severity of hemoptysis, 
past-history of tuberculosis, affected side of the 
lung and type of surgery done (14-16) were 
evaluated by multivariate analysis with stepwise 
backward elimination method to determine the 
independent predictors of postoperative 
complications. Statistical analyses were 
performed using SPSS 23.0 (IBM Corporation, 
Armonk, NY, USA). For all tests, a value of 




Socio-demographic profile: Out of the 72 
patients included in the study, there were 
46(63.9%) males and 26(36.1%) females with 
male-to-female ratio of 1.8:1. The mean age 
affected was 35.2 +/-11.6 years (range 16 - 65). 
The age group 25-49 years, 53(73.6%) was 
predominantly affected. Besides, the majority of 
patients came from urban areas, 43(59.7%), and 
were married, 43(59.7%) (Table 1). 
 
Diagnosis: The diagnosis of PA was based on 
clinical features and diagnostic investigations. 
Cough, 72(100%), and hemoptysis, 72(100%), 
were the primary symptoms reported in all 
patients.  Other symptoms were pain, 
50(69.4%), fever, 26(36.1%), and SOB, 
36(50%). The majority of the patients had mild 
hemoptysis, 40(55.6%). Only 16(22.2%) had a 
history of severe hemoptysis.  
        All patients were treated for pulmonary 
tuberculosis, and 49(68%) of them were treated 
for more than one time. The time between the 
first incidence of pulmonary tuberculosis and 
subsequent development of aspergilloma was 
variable (range 1- 20 years). Concomitant 
illnesses identified were diabetes mellitus, 
2(2.8%), and HIV infection, 2(2.8%). The vital 
sign was deranged in 9(12.5%) patients, and 
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Table 1: Analysis of demographics, Clinical features and its relation to Postoperative complications done 
at Tikur Anbessa Specialized Hospital and Menilik the 2nd Hospital from Nov 30, 2014 – Nov30, 2019 
1Pearson Chi-Square, *reference group used to calculate AOR. 
 
An initial plain chest x-ray was done for 
70(97.2%) patients and demonstrated a cavitary 
lesion with a hyperdensity within it. 
Subsequently, CT scan was done for all patients, 
and the diagnosis of PA was made by 
identifying air crescent sign (Figure 1,2). CT 
scan was also used to further characterize the 
lesion, to assess the involved site and lobe of the 
lung and to assess the concomitant disease of the 
lung. Almost all patients had upper lobe 
aspergilloma, 71(98.6%), with only one (1.4%) 





When the performance status of the patient was 
doubtful, the pulmonary function test was used 
in 17(23.6%) patients that help a better 
understanding of the general condition. For 
suspected malignant cavitary lesion, 
bronchoscopy and BAL cytology were done on 
12(16.7%) patients which demonstrated fungal 
hyphae. Due to the lack of test reagent, the 
serologic examination to identify possible fungal 
infection was not done. During surgery, a ball of 
fungus was demonstrated in all patients, and 
histologic examination was made for only 
11(15.3%) malignant suspected specimens and it 
demonstrated only A. fumigatus.  
 
                                                       Postoperative Complications   
 No(%) Yes(%) Total (%) P-Value1 AOR 95%CI 
Demographics       
Sex – M 
        - F 
32(64) 14(63.6) 46(63.9) 0.976 1.016 0.358-2.883 
18(36) 8 (36.4) 26(36.1)    
Age ( years)                    35.2 +/-11.6                                           0.445                                             1.016 0.975-1.059 
Age (Years)        
        - < 25* 8(16) 3(13.6) 11(15.3) 0.647 1.259 0.470-3.373 
        - 25-49 37(74) 16(72.7) 53(73.6)    
        - >49 5(10) 3(13.6) 8(11.1)    
Address        
       - Urban 33(66) 10(45.5) 43(59.7) 0.105 2.329 0.837-6.480 
       - Rural 17(34) 12(54.5) 29(40.3)    
Marital status       
    - Single* 16(32) 11(50) 27(37.5) 0.478 1.385 0564-3.404 
    - Married 32(64) 11(50) 43(59.7)    
    - Widowed 2(4) 0(0) 2(2.8)    
Clinical features       
Cough 50(100) 22(100) 72(100)                  -    -         - 
 Pain 35(70) 15(68.2) 50(69.4) 0.877 0.918 0.311-2.710 
Hemoptysis        
         - Mild* 29(58) 11(50) 40(55.6) 0.917 1.033 0.560-1.905 
          - Moderate 9(18) 7(31.8) 16(22.2)    
          - Severe 12(24) 4(18.2) 16(22.2)    
 Fever 17(34) 9(40.9) 26(36.1) 0.575 1.344 0.479-3.771 
SOB 23(46) 13(59.1) 36(50) 0.308 1.696 0.614-4.682 
Tuberculosis 50(100) 22(100) 72(100)             -     -         - 
Diabetes Mellitus 1(2) 1(4.5) 2(2.8) 0.556 2.333 0.139-39.08 
 HIV - Positive* 1(2) 1(4.5) 2(2.8) 0.432 0.685 0.267-1.760 
         - Negative 11(22) 6(27.3) 17(23.6)    
         - Unknown 38(76) 15(68.2) 53(73.6)    
Deranged V/S 8(16) 1(4.5) 9(12.5) 0.205 0.250 0.029-2.133 
Pallor 12(24) 5(22.7) 17(23.6) 0.907 0.931 0.283-3.061 
              
            Surgical Outcome of Chronic Pulmonary Aspergilloma…                      Berhanu N.A.  et al.                     
 
 







                




      Figure 2: Figure 2: Left upper lobe intra-cavitary mass, with an air crescent sign 
                       
Operative procedures and follow-up: Double 
lumen Endo-tracheal intubation was used in 
46(63.9%) patients. The rest, 26(36.1%) 
patients, were operated with single-lumen 
endotracheal tubes. The left lung and right lung 
were affected in 45(62.5%) and 27(37.5%) 
patients respectively. In all cases, the pleural 
surface was found extensively adherent to the 
chest wall and was difficult to dissect. The type 
of procedures done was Lobectomy, 32(44.4%), 
pneumonectomy, 12(16.7%), Bi-lobectomies, 
7(9.7%), and cavernostomy, 21(29.2%). The 
estimated average intra-operative blood loss was 
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Table 2: Analysis of the location of aspergilloma, affected lobe, type of endotracheal tube used, type of 
surgery, the estimated blood loss and its relation to Postoperative complications done at Tikur Anbessa 
Specialized Hospital and Menillik the 2nd Hospital from Nov 30,2014-Nov 30, 2019. 
1Pearson Chi-Square, *reference group used to calculate AOR
During the initial 30 days of postoperative 
hospital stay, 21(29.1%) patients developed one 
or more complications.  The major postoperative 
complications seen were prolonged air leak, 
7(9.7%), Pneumonia, 3(4.2%), empyema, 
7(9.7%), wound infection, 3 (4.2%), and others, 
1(1.4). Five (6.9%) patients had significant 
intraoperative bleeding of which one died due to 
exsanguinating bleeding from major vessel 
injury. The other two patients died due to 
respiratory failure and sepsis which happened 
after pneumonectomy and lobectomy 
respectively. The overall mortality within 30 
days of surgery was 3(4.2%), and the rest 95.8% 









Table 3: Frequency table of intraoperative and 
postoperative complications done at Tikur Anbessa 
Specialized Hospital and Menillik the 2nd Hospital 
from Nov 30, 2014 – Nov30, 2019. 
 
Adverse Outcome Number  Percent 
Intraoperative Complications   
Massive bleeding 5 6.9 
Lung lacerations 1 1.4 
Death   1 1.4 
Others 2 2.8 
Total 9 12.5 
Postoperative Complications   
Pneumonia 3 4.2 
Empyema 7 9.7 
Broncho pleural fistula 7 9.7 
Wound infection 3 4.2 
Death 2 2.8 
Others 1 1.4 
Total 23 31.9 
Grand Total   
No complication 48 66.6 
Morbidity 21 29.1 
Mortality 3   4.2 
          Postoperative complications   
 No (%) Yes (%) Total (%) P-Value1 AOR 95%CI 
Location                 
       - Right                 15(30) 13(59) 28(38.8) 0.022 0.297 0.105-0.842 
       - Left 35(70) 9(40.9) 44(61.1)    
Affected lobe        
   - Upper 50(100)    21(95.5) 71(98.6) - - - 
   - Middle 0(0) 1(4.5) 1(1.4)    
   - Lower 0(0) 0(0) 0(0)    
ETT           
   - Single 17(34) 9(40.9) 26(36.1) 0.575 0.744 0.265-2.088 
   - Double  33(66) 13(59.1) 46(63.9)    
Surgery       
   - Pneumonectomy*    4(8) 8(36.4) 12(16.7) 0.011 0.486 0.279-0.847 
   - Lobectomy 23(46) 9(40) 32(44.4)    
   - Bi-lobectomy  5(10) 2(9.1) 7(9.7)    
   - Cavernostomy 18(36) 3(13.6) 21(29.2)    
Intraoperative 
complication 
      
    - No 47(94) 16(77.3) 63(88.9) 0.020 5.875 1.31-26.26 
    - Yes 3(6) 6(22.7) 9(11.1)    
Estimated blood loss 745+/-307ml  0.984 1.000 0.998-1.002 
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Those patients who improved were discharged 
and followed for a median of 5 months (range 2 
weeks to 24 months) at the surgical referral 
clinic. During the follow-up period, no 
significant addition of morbidity nor mortality 
was identified. Few patients were noticed to 
have received different antifungal treatment.  
Factors predicting adverse outcome: Analysis 
of the postoperative complications between the 
type of surgery varied between 9.1% and 40%. It 
was further evaluated with the chi-square test 
and a significant difference was detected (p-
value=0.011). Patients with pneumonectomy/ 
lobectomy were most likely to develop 
complications than those with cavernostomy or 
Bi-lobectomy. In the bivariate logistic regression 
models, the affected site of the lung, type of 
surgery done and the presence of intraoperative 
complications, were identified to have a 
significant association with postoperative 
complications. Postoperative outcome 
(complication) was significantly affected by the 
location of the aspergilloma [(P=0.022; AOR= - 
0.297; 95%CI)], the type of procedure 
performed [(P=0.011; AOR= -0.486; 95%CI)] 
and the presence of intraoperative complications 




Pulmonary aspergilloma develops most frequently 
in residual tuberculosis cavities. The British 
Thoracic and Tuberculosis Association reported 
6% of patients with a healed tuberculosis cavity 
developing pulmonary aspergilloma within 3 years 
(17). Many studies also showed pulmonary 
tuberculosis as the most common pre-existing 
cavity lesion accounting for 32-45% (28,29). Chen 
QK from China reported that 71.1% of their 
patients with PA were treated for tuberculosis (9). 
In Ethiopia, due to the high incidence of 
tuberculosis, it is not uncommon to see patients 
with PA (6). In this study, all patients were 
previously treated for tuberculosis, and the 
majority of them placed on a repeated course of 
anti-tuberculosis treatment. This finding of patients 
being referred for surgery after treated multiple 
times for tuberculosis could indicate a wrong effort 
to resolve PA. This observation in delay referral 
and possibly wrong treatment of PA requires 
further study. 
Similar to other studies, males are affected more 
than females (9). Unlike this study, patients with 
PA in developed countries typically were found in 
their middle ages. In a series of 18 patients with 
chronic pulmonary aspergillosis done in the United 
Kingdom, the median age affected was 59 years 
(2). According to United Nations data 
(April12,2020), the median age in Ethiopian 
population is 19.5 years. A similar finding of 
higher proportion of the younger patients with PA 
was also noticed in this study (17-19). 
        Clinical presentation of PA ranges from an 
incidental radiological finding to exsanguinating 
hemoptysis (20). In our series, cough and 
hemoptysis were the primary symptoms reported 
in all patients. Chest pain, SOB, and fever were 
also reported in half of the cases. A similar study 
was done in India which reported hemoptysis in 
79.16% patients (21). Bleeding during pulmonary 
aspergilloma usually arises from the bronchial 
arteries, and it stops spontaneously (22,23). 
However, when the cavity erodes into the 
intercostal vessel, the hemoptysis is severe and is 
unlikely to stop.  
         All fungal balls in this series were found in 
the upper lobe. This is because the healed 
tuberculosis cavities in the upper lobe serve as a 
good nidus for colonization with A. fumigatus. 
Many studies reported a similar association (range 
13%-89%) (21-23).  
Even though HIV infection is a common 
problem in our society, 73.6% of the patients in 
this study were not tested for HIV infection. 
Among those tested, only 2/19 were tested 
positive. Similar studies showed that since the 
introduction of potent ART, the incidence of 
aspergilloma in HIV-infected patients is low. In a 
review of 342 cases of pulmonary aspergillosis and 
invasive disease with AIDS, only 14 patients were 
diagnosed with aspergillomas (12). In this study, a 
low association of PA with another disease like 
diabetes mellitus was also identified. 
           The surgical management of pulmonary 
aspergilloma is challenging and controversial. No 
double-blind, placebo-control or randomized trials 
have been undertaken. According to Shakil et al 
(24), among the 30 patients operated for PA, 23 
were symptomatic and were treated with 
preoperative antifungal treatment. In this study, 
although all patients were symptomatic, they were 
operated without receiving preoperative antifungal 
treatment. 
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In 2008, a guideline for the treatment of 
aspergillosis was developed by the Infectious 
Diseases Society of America. The guideline 
recommends an approach to therapy by 
distinguishing ‘simple aspergilloma’ from the 
more complex forms of ‘chronic cavitary 
pulmonary aspergillosis’ and ‘chronic fibrosing 
pulmonary aspergillosis’ (13). Nevertheless, such 
kind of diagnostic and therapeutic approach was 
not followed in the management of our patients.  
          Surgical treatment for simple aspergilloma is 
done to prevent or treat potentially life-threatening 
complications, which usually is curative (14,15). 
The role of antifungal treatment for simple 
aspergilloma is controversial. Many patients, such 
as those who are asymptomatic and have stable 
radiographic findings over many months, may not 
require therapy (14). However, if surgery is 
indicated for symptomatic PA, the use of pre- and 
post-operative antifungal therapy (usually 
variconazole) is recommended. This is because 
during operation, most cavities will inadvertently 
be opened that leads to spillage, which increases 
the risk of postoperative aspergillosis (14,25,26). 
The use of postoperative antifungal treatment in 
this study was found to be inconsistent. Hence, 
based on the current recommendation, a protocol 
on the use of antifungal treatment before and after 
surgery need to be developed. 
          In contrast to patients with simple 
aspergilloma, those with chronic cavitary 
pulmonary aspergillosis and chronic fibrosing 
pulmonary aspergillosis require life-long 
antifungal therapy, a practice that was not reported 
in our cases management (12-14). The evidence 
regarding the efficacy of long-term antifungal 
therapy for such diseases was based on small case 
series and open-label non-comparative studies. 
According to those studies, Itraconazole and 
voriconazole are the preferred oral agents. They 
also reported that discontinuation of therapy could 
lead to a gradual return of symptoms, manifested 
with worsening of chest radiography findings, and 
rising level of Aspergill (14-16). Surgical 
outcomes for this category of diseases were not as 
good as those for simple aspergillomas (12,13).
  
         In general, because of the treatment of 
massive hemoptysis, surgical resection remains the 
mainstay of treatment for PA. However, no agreed 
document exists on the extent of lung resection. In 
this study, patients with 
pneumonectomy/lobectomy did not have favorable 
outcomes compared with those cavernostomy/ bi-
lobectomy group. This finding is consistent with a 
previous study (9,19,). Similarly, Shirakusa et al. 
advocate a limited lung resection (27). However, 
studies showed that radical resection of the 
affected areas had effectively improved patient 
outcomes. Because of this argument, many case 
series studies advocate a standard thoracotomy and 
lobectomy to be the preferred surgical procedures 
(7-11,18-23). In this series, lobectomy was done 
for 44.4% of patients. Studies recommend 
pneumonectomy only when the affected lung was 
destroyed or the remaining lobe was severely 
fibrotic and small, which cannot expand to fill the 
chest cavity (7). Cavernostomy was done primarily 
for either peripheral placed small PA or when the 
fungal ball lies close to the fissure or hilum and 
pneumonectomy was not an option because of the 
patient’s general condition. Similar to other 
studies, (19-21, 28-32), the postoperative 
complications related to it were significantly low 
(P=0.011). Cavernostomy is now considered as a 
viable treatment alternative even to those that can 
be submitted to pulmonary resection. 
We investigated the risk factors of 
postoperative complications and short-term 
observation of patients with PA. Among the study 
population, 21(29.1%) of the patients developed 
postoperative complications. At risk-adjusted 
analysis, socio-demographic characteristics and 
clinical presentations showed no effect on the 
incidence of adverse events. However, the affected 
side of the lung, the type of surgery done, and the 
presence of intraoperative complications were 
revealed as the independent predictors of 
postoperative complications. The reason for the 
higher postoperative complication in the right lung 
surgery is unclear. 
Previous studies reported operative mortality 
rates to range from 4 to 22%, (34-37) and 
postoperative complications of 15-78%, (28) with 
the current surgical and anesthetic advances; recent 
reports show an improved outcome (34). Several 
of such series describe acceptable outcomes with 2 
to 5% mortality and 25% overall complication rate 
(28-35) Overall, the result of this study is equally 
favorable to other recent results. 
Some of the limitations of this study include 
the following. First the size of the study population 
is relatively small. Second, because of the study 
design (retrospective cross-section) selection bias 
towards selecting more symptomatic and referred 
patients than asymptomatic and not referred 
patients is expected. Third, Bronchoscopy and 
cytology were done for only 16.7% of patients. 
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The diagnosis was primarily based on the 
radiologic and intraoperative findings. Hence, 
some diseases like actinomycosis, nocardiosis, 
intracavitary hematoma, and adenocarcinoma, 
could mimic PA. (32). Fourth, because of the 
extended time period between first incidence of 
tuberculosis and subsequent development of 
aspergilloma, it is difficult to ascertain the exact 
time which may result in a recall bias. And fifth, 
the duration of follow-up was relatively short, and 
the long-term outcome of surgery is not known. 
Therefore, a well-designed prospective cohort 
study is recommended to confirm the association 
between different variables and the immediate and 
long-term adverse outcome.  
Finally, the study represents one of the largest 
surgical experience in Sub-Saharan countries with 
a resource-limited setup. An outcome, which was 
comparable with many international studies done 
in developed countries was achieved. It is, 
therefore, logical to recommend operative 
resection of the involved area of the lung with a 
thorough preoperative assessment and a careful 
evaluation of the risk/benefit ratio is made. 
In conclusion, since pulmonary aspergilloma 
represents a spectrum of different disease stages, 
and the risks and benefits of medical and surgical 
therapy vary with the manifestations of the disease 
and the patient's pulmonary status, the approach to 
therapy should be individualized. To improve our 
patients’ outcome, treating aspergilloma patients in 
line with those of the 2008 Infectious Diseases 
Society of America guidelines is recommendable 
(13).   
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